From: Prognosis of West Nile virus associated acute flaccid paralysis: a case series
 | Baseline characteristics | Presenting clinical features | Therapeutic interventions | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Case | Age | Sex | Co-morbidity | Fever | Involved sites | Intubation | CSF WBC (cells/μl) | CSF protein (g/L) | PT | OT | Antidepressants |
1 | 55y | M | None | No | LUE | No | - | - | Yes | No | No |
2 | 54y | M | Hypertension Dyslipidemia | No | Bilateral UE | No | <5 | <0.45 | No | No | No |
3 | 66y | F | None | No | Bilateral UE and LE | Yes | 123 | 1.27 | Yes | Yes | No |
4 | 67y | M | None | No | RLE | No | 189 | 1.04 | Yes | No | No |
5 | 60y | F | None | No | Bilateral LE | No | 32 | 0.77 | Yes | No | Yes (citalopram) |
6 | 71y | M | Heart failure Parkinson's | Yes | Bilateral LE | No | <5 | 1.06 | Yes | Yes | No |
7 | 52y | M | None | No | RLE | No | 39 | 1.35 | Yes | No | No |